7. Neutron Capture Therapy

Abstract

In case that corrections are made, overwrite the modified version in the following web page: https://www.rri.kyoto-u.ac.jp/PUB/report/PR/ProgRep2024/ProgRep2024.htmlCO7-1 Antitumor effect of boron neurton capture therapy in cervical cancer mouse model/ A Toji et al. (R6001) [193]CO7-2 The effect of boron neutron capture therapy (BNCT) to gastrointestinal stromal tumor cell line GIST-T1/ S. Hagihara et al. (R6002) [194]CO7-3 The effect of boron neutron capture therapy (BNCT) to liver metastasis of colorectal cancer/ Y. Ueda et al. (R6003) [195]CO7-4 Development of a Therapeutic Agent for Bone Metastases with Nuclear Imaging and Boron Neutron Capture Therapy/ K. Ogawa et al. (R6006) [196]CO7-5 Examination of improvement of BNCT treatment efficiency by L-phenylalanine deficiency in mice tumor models/ Y. Tamari et al. (R6010) [197]CO7-6 Basic research on new BNCT strategies for melanoma/ H. Michiue et al. (R6012) [198]CO7-7 Cytosolic Delivery Technology Using Cationic Lipids in BNCT/ S. Hirase et al. (R6017) [199]CO7-8 Neutron irradiation experiments using a novel BPA formulation based on ionic liquids/ M. Shirakawa et al. (R6018) [200]CO7-9 Investigation of boron drug using albumin-binding polymer modified with boron clusters/ K. Banshoya et al. (R6019) [201]CO7-10 Development of boron rich nanostructure with amphiphilic block polymers as boron agents for BNCT/ R. Kawasaki et al. (R6022) [202]CO7-11 Development of a Water-Soluble Small Molecule Boron Carrier Targeting Biotin Receptors for Neutron Capture Therapy/ H. Nakamura et al. (R6024) [203]CO7-12 BNCT Effect of PBC-IP on Head and Neck Squamous Cell Carcinoma Mouse Model/ K. Miura et al. (R6025) [204]CO7-13 Construction of novel Boron-containing silica nanoparticles and BNCT experiments/ F. Tamanoi et al. (R6030) [205]CO7-14 Synthesis of PEPT1-targeted boron containing dipeptids for pancreatic cancer therapy/ F. Tamanoi et al. (R6032) [206]CO7-15 Sensitization of BPA-BNCT by Regulating the Polarity of Tumor-Associated Macrophage Using Shikonin/ N. Takabayashi et al. (R6037) [207]CO7-16 Boosting Antitumour Efficacy and Immunity by BNCT with Size-Controlled Nanoparticles/ W. Huang et al. (R6038) [208]CO7-17 Development of boron carriers based on the characteristics of energy metabolism of cancer/ R. Yamamoto et al. (R6040) [209]CO7-18 Tumour Growth Suppression by Neutron Capture Therapy using Intratumoral Administration of ¹⁰Boro-plex encapsulated Water-in-Oil-in-Water Emulsion/ H. Yanagie et al. (R6053) [210]CO7-19 Optimization of polymer-BPA conjugates for non-clinical studies/ T. Nomoto et al. (R6065) [211]CO7-20 Development of novel boron delivery systems improving accumulation contrast/ T. Nomoto et al. (R6066) [212]CO7-21 Development of Novel Small-molecule Boron Neutron Capture Therapy Drugs Targeting Tumor-specific Enzymatic Activity/ S. Kanai et al. (R6071) [213]CO7-22 Synthesis and evaluation of a novel boron neutron capture therapy agent/ H. Kimura et al. (R6072) [214]CO7-23 Measurements of two kinds of thimble-type ionization chambers for an intense epi-thermal neutron beam/ T. Matsumoto et al. (R6077) [215]CO7-24 Development of Nanogels Loaded with Gd(III)-Thiacalixarene Complex for Gd-NCT/ N. Iki et al. (R6092) [216]CO7-25 Research and Development of New Technology for Boron Neutron Capture Therapy/ M. Xu et al. (R6094) [217]CO7-26 Mechanism of Glioma Resistance After BNCT via Small Extracellular Vesicles/ N. Kondo et al. (R6096) [218]CO7-27 Characterization of Solar Cell-Based Radiation Detectors for BNCT Applications/ Y. Okuno et al. (R6098) [219]CO7-28 Establishment of innovative BNCT treatment method for intractable bladder cancer/ P. Huang et al. (R6109) [220]CO7-29 Evaluation of a novel cyclodextrin-based polyrotaxane boron compound for BNCT/ Y. Matsumoto et al. (R6111) [221]CO7-30 Attempts to sensitize tumor cells by exploiting the tumor microenvironment/ Y. Sanada et al. (R6115) [222]CO7-31 Tumor responses after BNCT at early stages/ Y. Tong et al. (R6119) [223]CO7-32 BNCT with a novel boron drug, BBCIP, for a rat brain tumor model/ K. Eza et al. (R6123) [224]CO7-33 Pathological Assessment of Boron Neutron Capture Therapy with CED-Based Delivery of FRα-Targeting PBC-IP in Non-Tumor-Bearing Rats/ K. Tsujino et al. (R6124) [225]CO7-34 Exploring Boron Neutron Capture Therapy for Chordoma: Experimental Study/ Y. Fujikawa et al. (R6125) [226]CO7-35 Deviation of Important Elements for Activation in Three Types of Ordinary Concrete for Radiation Shielding/ K. Kimura et al. (R6127) [227]CO7-36 Detection of -Borono-L-phenylalanine (BPA) Absorbed in Rice Seeds Using a Boron Neutron Capture Reaction/ T. Kinouchi et al (R6142) [228]CO7-37 Investigation of Potential Adverse Effects of Boron Neutron Capture Therapy on Host Immunity/ T. Watanabe et al. (R6144) [229]CO7-38 Investigation of Potential Adverse Effects of Boron Neutron Capture Therapy on Host Immunity/ T. Watanabe et al. (R6146) [230]CO7-39 Combining GdNCT and anti-PD-1 immunotherapy to boost abscopal effect/ L. Zhao et al. (R6150) [231]CO7-40 Investigation of nano-boron drugs for BNCT/ Z. Zhang et al. (R6151) [232]CO7-41 Analysis of the Structural Change of Boron Compounds after Boron Neutron Capture Reaction/ H. Ueda et al. (R6156) [233]CO7-42 Evaluation of a Retinoid X Receptor-Binding BSH Derivative for Inhibition of Cell Proliferation Under Neutron Irradiation/ A. Mashimo et al. (R6163) [234]CO7-43 Investigation of Boron Neutron Capture Reaction by Iodine-containing BSH Derivatives/ A. Mashimo et al. (R6164) [235]CO7-44 Safety of Boronated matrix metalloproteinase ligand 1 / N. Kondo et al. (R6165) [236]CO7-45 Investigation of cellular senescence by BNCT/ M. Suzuki et al. (R6167) [237]CO7-46 Clarification of the normal cell fractionation as a trigger for radiation-induced liver injury/ M. Suzuki et al. (R6168) [238